Post COVID-19 Symptoms: A Neglected Domain

Background: COVID -19 is the most important public health problem of recent time. Most people who have COVID-19 recovers completely within a few weeks but some people continue to have symptoms after initial recovery. Objective: To assess the prevalence of Post COVID symptoms, to assess requirement of treatment and to make recommendation for Post COVID care. Methods: Present cross sectional study was done among patients who recovered from COVID-19 in Meerut district. Mobile numbers of COVID patients were obtained from records, Total 100 randomly selected patients were contacted using google form and information regarding post covid symptoms in between 6 weeks to 12 weeks after recovery from COVID was obtained. Result: 87%patients developed one or more post covid symptoms. Weakness was reported to be most common problem (55%), followed by body ache (26%) and neuropsychiatric symptoms such as difficulty in concentration and insomnia (22%). Every fifth patient reported that symptoms persisted for more than 1 month. Though most of the respondents classified their symptoms as mild and moderate (52.5% and 37.9% respectively), 47% of the symptomatic patients have to take some treatment for these symptoms. Conclusion: Post COVID symptoms are common but usually less severe . Some form of treatment was required to deal with problem. Almost one in five patients reported that symptoms persisted for more than one month. The results highlight the need for post Covid care for COVID recovered patients

Towards Language Models That Can See: Computer Vision Through the LENS of Natural Language

We propose LENS, a modular approach for tackling computer vision problems by leveraging the power of large language models (LLMs). Our system uses a language model to reason over outputs from a set of independent and highly descriptive vision modules that provide exhaustive information about an image. We evaluate the approach on pure computer vision settings such as zero- and few-shot object recognition, as well as on vision and language problems. LENS can be applied to any off-the-shelf LLM and we find that the LLMs with LENS perform highly competitively with much bigger and much more sophisticated systems, without any multimodal training whatsoever. We open-source our code at https://github.com/ContextualAI/lens and provide an interactive demo

Cell cycle-dependent regulation of the bi-directional overlapping promoter of human BRCA2/ZAR2 genes in breast cancer cells

<p>Abstract</p> <p>Background</p> <p>BRCA2 gene expression is tightly regulated during the cell cycle in human breast cells. The expression of BRCA2 gene is silenced at the G0/G1 phase of cell growth and is de-silenced at the S/G2 phase. While studying the activity of BRCA2 gene promoter in breast cancer cells, we discovered that this promoter has bi-directional activity and the product of the reverse activity (a ZAR1-like protein, we named ZAR2) silences the forward promoter at the G0/G1 phase of the cell. Standard techniques like cell synchronization by serum starvation, flow cytometry, N-terminal or C-terminal FLAG epitope-tagged protein expression, immunofluorescence confocal microscopy, dual luciferase assay for promoter evaluation, and chromatin immunoprecipitation assay were employed during this study.</p> <p>Results</p> <p>Human <it>BRCA2 </it>gene promoter is active in both the forward and the reverse orientations. This promoter is 8-20 fold more active in the reverse orientation than in the forward orientation when the cells are in the non-dividing stage (G0/G1). When the cells are in the dividing state (S/G₂), the forward activity of the promoter is 5-8 folds higher than the reverse activity. The reverse activity transcribes the ZAR2 mRNA with 966 nt coding sequence which codes for a 321 amino acid protein. ZAR2 has two C4 type zinc fingers at the carboxyl terminus. In the G0/G1 growth phase ZAR2 is predominantly located inside the nucleus of the breast cells, binds to the BRCA2 promoter and inhibits the expression of BRCA2. In the dividing cells, ZAR2 is trapped in the cytoplasm.</p> <p>Conclusions</p> <p><it>BRCA2 </it>gene promoter has bi-directional activity, expressing BRCA2 and a novel C4-type zinc finger containing transcription factor ZAR2. Subcellular location of ZAR2 and its expression from the reverse promoter of the BRCA2 gene are stringently regulated in a cell cycle dependent manner. ZAR2 binds to BRCA2/ZAR2 bi-directional promoter <it>in vivo </it>and is responsible, at least in part, for the silencing of BRCA2 gene expression in the G0/G1 phase in human breast cells.</p

Effects of glenohumeral corticosteroid injection on stiffness following arthroscopic rotator cuff repair: a prospective, multicentric, case-control study with 18-month follow-up

Background This study aimed to analyze the efficacy of single-dose corticosteroid injection (CSI) administered at 6 weeks postoperative to treat stiffness following arthroscopic rotator cuff repair (ARCR). Methods In this prospective, multicentric, case-control study, post-ARCR stiffness at 6 weeks was treated with either a single dose of intra-articular CSI (CSI group) or physical therapy with oral analgesics (non-CSI group). Pain intensity according to visual analog scale (VAS), functional outcome using the Constant Murley Shoulder Score, time to return to activities of daily living (ADLs), and retear rate were recorded at 6 weeks, 9 weeks, 12 weeks, 6 months, 12 months, and 18 months postoperatively in both groups. Results A total of 149 patients (54.5%) in the CSI group and 124 patients (45.5%) in the non-CSI group were included in this study. Pain and function were significantly better in the CSI group at 9-week, 12-week, and 6-month (P<0.001) follow-up, whereas they were not significantly different when the groups were compared at 12- and 18-month follow-up. The mean duration to return to ADLs was significantly shorter (P<0.001) in the CSI group. The incidence of retears was not significantly different (P=0.36) between groups at the end of 18 months of follow-up. Conclusions Single-dose intra-articular CSI administered at 6 weeks postoperative to treat post-ARCR stiffness significantly improved pain, function, and duration of return to ADLs without increasing the risk of retears compared to patients who did not receive intra-articular CSI. Level of evidence III

Chelation in Metal Intoxication

Chelation therapy is the preferred medical treatment for reducing the toxic effects of metals. Chelating agents are capable of binding to toxic metal ions to form complex structures which are easily excreted from the body removing them from intracellular or extracellular spaces. 2,3-Dimercaprol has long been the mainstay of chelation therapy for lead or arsenic poisoning, however its serious side effects have led researchers to develop less toxic analogues. Hydrophilic chelators like meso-2,3-dimercaptosuccinic acid effectively promote renal metal excretion, but their ability to access intracellular metals is weak. Newer strategies to address these drawbacks like combination therapy (use of structurally different chelating agents) or co-administration of antioxidants have been reported recently. In this review we provide an update of the existing chelating agents and the various strategies available for the treatment of heavy metals and metalloid intoxications

Steady separated flow past a circular cylinder at low Reynolds numbers

The steady two-dimensional laminar flow around a stationary circular cylinder has been investigated via a stabilized finite-element method. The Reynolds number Re is based on the cylinder diameter and free-stream speed. The results have been presented for 6 &#8804; Re&#8804; 40 and the blockages between 0.000125 and 0.80. The blockage B is the ratio of the cylinder diameter to the domain width. There is large scatter in the value of Res, reported in the literature, marking the onset of the flow separation. From the present study the Res is found to be 6.29, approximately for B = 0.005. The effect of the blockage on the characteristic flow parameters is found to be insignificant for B &#8804; 0.01. The bubble length, separation angle and Res exhibit non-monotonic variation with the blockage. It is for the first time that such a behaviour for the separation angle and Res is being reported. Two types of boundary conditions at the lateral walls have been studied: the slip wall and towing tank. In general for high blockage, the results from the slip boundary condition are closer to the ones for the unbounded flow. In that sense, the use of the slip boundary condition as opposed to the towing tank boundary condition on the lateral walls is advocated. The bubble length, separation angle, base suction, total drag, pressure drag, viscous drag and maximum vorticity on the cylinder surface for the steady flow are found to vary as Re, Re-0.5, Re-1, Re-0.5, Re-0.64, Re-0.60 and Re0.5, respectively. The extrapolated results for the steady flow, for higher Re, are found to match quite well with the other results from the literature

Essential Oils and Their Constituents as Anticancer Agents: A Mechanistic View

Exploring natural plant products as an option to find new chemical entities as anticancer agents is one of the fastest growing areas of research. Recently, in the last decade, essential oils (EOs) have been under study for their use in cancer therapy and the present review is an attempt to collect and document the available studies indicating EOs and their constituents as anticancer agents. This review enlists nearly 130 studies of EOs from various plant species and their constituents that have been studied so far for their anticancer potential and these studies have been classified as in vitro and in vivo studies for EOs and their constituents. This review also highlights in-depth various mechanisms of action of different EOs and their constituents reported in the treatment strategies for different types of cancer. The current review indicates that EOs and their constituents act by multiple pathways and mechanisms involving apoptosis, cell cycle arrest, antimetastatic and antiangiogenic, increased levels of reactive oxygen and nitrogen species (ROS/RNS), DNA repair modulation, and others to demonstrate their antiproliferative activity in the cancer cell. The effect of EOs and their constituents on tumour suppressor proteins (p53 and Akt), transcription factors (NF-κB and AP-1), MAPK-pathway, and detoxification enzymes like SOD, catalase, glutathione peroxidase, and glutathione reductase has also been discussed

Flow past a square cylinder at low Reynolds numbers

Results are presented for the flow past a stationary square cylinder at zero incidence for Reynolds number, Re ≤ 150. A stabilized finite-element formulation is employed to discretize the equations of incompressible fluid flow in two-dimensions. For the first time, values of the laminar separation Reynolds number, Res, and separation angle, θ s, at Res are predicted. Also, the variation of θ s with Re is presented. It is found that the steady separation initiates at Re = 1.15. Contrary to the popular belief that separation originates at the rear sharp corners, it is found to originate from the base point, i.e. θ s=180° at Re = Res. For Re &gt; 5, θ s approaches the limit of 135 ° . The length of the separation bubble increases approximately linearly with increasing Re. The drag coefficient varies as Re-0.66. Flow characteristics at Re ≤ 40 are also presented for elliptical cylinders of aspect ratios 0.2, 0.5, 0.8 and 1 (circle) having the same characteristic dimension as the square and major axis oriented normal to the free-stream. Compared with a circular cylinder, the flow separates at a much lower Re from a square cylinder leading to the formation of a bigger wake (larger bubble length and width). Consequently, at a given Re, the drag on a square cylinder is more than the drag of a circular cylinder. This suggests that a cylinder with square section is more bluff than the one with circular section. Among all the cylinder shapes studied, the square cylinder with sharp corners generates the largest amount of drag

Credit financing for deteriorating imperfect quality items with allowable shortages

The outset of new technologies, systems and applications in manufacturing sector has no doubt lighten up our workload, yet the chance causes of variation in production system cannot be eliminated completely. Every produced/ordered lot may have some fraction of defectives which may vary from process to process. In addition the situation is more susceptible when the items are deteriorating in nature. However, the defective items can be secluded from the good quality lot through a careful inspection process. Thus, a screening process is obligatory in today’s technology driven industry which has the customer satisfaction as its only motto. Moreover, in order to survive in the current global markets, credit financing has been proven a very influential promotional tool to attract new customers and a good inducement policy for the retailers. Keeping this scenario in mind, the present paper investigates an inventory model for a retailer dealing with imperfect quality deteriorating items under permissible delay in payments. Shortages are allowed and fully backlogged. This model jointly optimizes the order quantity and shortages by maximizing the expected total profit. A mathematical model is developed to depict this scenario. Results have been validated with the help of numerical example. Comprehensive sensitivity analysis has also been presented